(Q34170359)

31 July 2017

1 reference

title

Alcohol-induced liver disease. (English)

1 reference

31 July 2017

Maddrey WC

1

1 reference

31 July 2017

publication date

1 February 2000

1 reference

31 July 2017

published in

Clinics in liver disease

1 reference

31 July 2017

volume

4

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

115-31, vii

1 reference

31 July 2017

cites work

Alcoholic Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Formation of extracellular matrix in normal rat liver: lipocytes as a major source of proteoglycan.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Pathogenesis of alcohol-induced accumulation of protein in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Increased plasma tumor necrosis factor in severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Genetic factors in alcohol metabolism and alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Serological and histological aspects of hepatitis C virus infection in alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Cell-mediated hepatic injury in alcoholic liver disease. Veterans Affairs Cooperative Study Group 275.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Chronic ethanol administration impairs receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Alcoholic liver disease: dose and threshold--new thoughts on an old topic

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Alcoholic liver disease: natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Alcohol-related trafficking accidents

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Effect of parenteral amino acid supplementation in alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

The effect of chronic ethanol feeding on ornithine decarboxylase activity and liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Rising incidence of hepatocellular carcinoma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Pathology of alcoholic liver disease. VA Cooperative Study Group 119.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Closing in on the signals of hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Alcoholic liver injury: defenestration in noncirrhotic livers--a scanning electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Early alcoholic liver injury. Activation of lipocytes in acinar zone 3 and correlation to degree of collagen formation in the Disse space

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

The increasing incidence of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Stimulation of monocyte interleukin-8 by lipid peroxidation products: a mechanism for alcohol-induced liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Effects of dexamethasone on albumin and collagen gene expression in primary cultures of adult rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Decreased hepatic glutathione in chronic alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Milestones in liver transplantation for alcoholic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Orthotopic liver transplantation for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Hepatic and other medical disorders of alcoholism: from pathogenesis to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Selection for and outcome of liver transplantation in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Histologic spectrum of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Is therapy with testosterone or anabolic-androgenic steroids useful in the treatment of alcoholic liver disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Alcoholic hepatitis: pathogenesis and approaches to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Lipocytes and transitional cells in alcoholic liver disease: A morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Cytokines and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Interaction Between Alcohol and Nutrition in the Pathogenesis of Alcoholic Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Hepatitis Bs antibody in alcoholic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Hepatitis C viremia and anti-HCV antibodies in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Intestinal endotoxins as mediators of hepatic injury--an idea whose time has come again

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Efficacy of interferon therapy in patients with chronic hepatitis C. Comparison between non-drinkers and drinkers

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Molecular regulation of hepatic fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Long-term treatment of alcoholic liver disease with propylthiouracil

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Reliability of assessment of alcohol intake based on personal interviews in a liver clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Immunologic reactions in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

A randomized trial of prednisolone in patients with severe alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Carbohydrate-deficient transferrin as a marker of alcohol consumption in male patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Should patients with end-stage alcoholic liver disease have a new liver?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Hepatitis C and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Serum secretory IgA and secretory component in patients with non-cirrhotic alcoholic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Survival and quality of life after liver transplantation for acute alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Liver transplantation for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Effects of ethanol on protein trafficking in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

The characteristics of alcoholic liver disease in Japan. Clinicopathologic comparison with alcoholic liver disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Immunoglobulin A in the diagnosis of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Sinusoidal caliber in alcoholic and nonalcoholic liver disease: diagnostic and pathogenic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Transcriptional and posttranscriptional effects of dexamethasone on albumin and procollagen messenger RNAs in murine schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Ito-cell gene expression and collagen regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Impact of alcohol on the histological and clinical progression of hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Perivenular fibrosis as precursor lesion of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970099-4

7 January 2021

10.1016/S1089-3261(05)70099-4

Identifiers

DOI

1 reference

31 July 2017

1 reference